KD Logo

Director MCDADE MARK acquire 100,000 shares of Tourmaline Bio Inc [TRML]

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tourmaline Bio Inc shares valued at $3,250,000 were purchased by MCDADE MARK on Jan 29 ’24. At $32.50 per share, MCDADE MARK acquired 100,000 shares. The insider’s holdings grew to 448,431 shares worth approximately $6.0 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Kulkarni Sandeep Chidambar purchased 4,000 shares, netting a total of over 67,960 in proceeds. Following the buying of shares at $16.99 each, the insider now holds 729,735 shares.

Before that, Thiara Parvinder had added 1,000 shares to its account. In a trade valued at $17,310, the Director bought Tourmaline Bio Inc shares for $17.31 each. Upon closing the transaction, the insider’s holdings increased to 1,000 shares, worth approximately $1.12 million.

As published in their initiating research note from Jefferies on December 15, 2023, Tourmaline Bio Inc [TRML] has been a Buy and the price target has been revised to $41. As of November 17, 2023, Truist has initiated its “Buy” rating for TRML. Earlier on October 31, 2023, Guggenheim initiated its rating. Their recommendation was “a Buy” for TRML stock.

Analyzing TRML Stock Performance

During the last five days, there has been a drop of approximately -4.70%. Over the course of the year, Tourmaline Bio Inc shares have dropped approximately -48.85%. Shares of the company reached a 52-week high of $48.31 on 03/13/24 and a 52-week low of $12.29 on 07/01/24. A 50-day SMA is recorded $14.68, while a 200-day SMA reached $23.76. Nevertheless, trading volume fell to 0.14 million shares from 0.43 million shares the previous day.

Support And Resistance Levels for Tourmaline Bio Inc (TRML)

According to the 24-hour chart, there is a support level at 12.35, which, if violated, would cause prices to drop to 11.88. In the upper region, resistance lies at 13.25. The next price resistance is at 13.67. RSI (Relative Strength Index) is 41.31 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.70, which suggests the price will decrease in the coming days. Percent R is at 88.98%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.

Most Popular